Abstract:Background: Apoptosis is an important cellular pathological process in D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-stimulated liver injury. Long noncoding RNAs (lncRNA) are involved in liver injury, but their mechanisms of action in fulminant hepatic failure (FHF) remain unclear. The aim of this study is to investigate the effect of NEAT1, an lncRNA, on apoptosis and proliferation of hepatocytes.Methods: Initially, we collected FHF clinical samples and established an in vitro cell model and an in vivo rat model of FHF by using (D-GalN)/LPS. The expression pattern of NEAT1 and LATS2 were then determined by RT-PCR and ELISA assay. Following the verification of the binding relationship between NEAT1, EZH2 and LATS2, gain-of- and loss-of-function experiments were applied to analyze the effects of NEAT1, EZH2 and LATS2 on hepatocyte proliferation and apoptosis, determined by EdU and Tunnel assay respectively. In addition, involvement of Hippo-YAP pathway was explored.Results: NEAT1 was highly expressed in FHF tissues, FHF cells and FHF rat model, in contrast LATS2 was downregulated. LATS2 was negatively correlated with NEAT1. After D-GalN/LPS treatment, NEAT1 inhibited the expression of LATS2 and cell proliferation, but promoted apoptosis. Furthermore, mechanistic investigation indicated that NEAT1 recruited EZH2 to LAST2 promoter region and mediate the methylation of H3K27me3, ultimately activate the Hippo-YAP axis. Besides, down-regulation of NEAT1 or overexpression of LAST2 inhibits liver injury caused by FHF in vivo.Conclusion: The NEAT1 modulate hepatocyte apoptosis in fulminant hepatic failure by recruiting EZH2 to LATS2 promoter region and promotes H3K27me3 methylation, highlighting new therapeutic directions in FHF.Funding: This study was supported by Hunan Provincial Natural Science Foundation Youth Fund Project (No. 2017JJ3427).Declaration of Interest: The authors declare that they have no competing interests.Ethical Approval: The study was approved by the ethics committee of the Third Xiangya Hospital of Central South University and the informed consents were singed by all participants or their guardians. The animal experiments are strictly designed and carried out according to the Guide for the Care and Use of Laboratory Animal by International Committees. Great efforts were made to minimize the number of animals used in the experiments and their suffering.

Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3

MiR-103-3p Promotes Hepatic Steatosis to Aggravate Nonalcoholic Fatty Liver Disease by Targeting of ACOX1

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease

ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway

Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway

MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes

LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation

Down‐regulation of lncRNA‐NEAT1 alleviated the non‐alcoholic fatty liver disease via mTOR/S6K1 signaling pathway

Lnc-Hc Ameliorates Steatosis by Promoting Mir-130B-3p Biogenesis and the Assembly of an RNA-induced Silencing Complex.

NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6

Effect of Mirna-10b in Regulating Cellular Steatosis Level by Targeting Ppar-Alpha Expression, A Novel Mechanism for the Pathogenesis of Nafld

Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response

Long Noncoding RNA FLRL2 Alleviated Nonalcoholic Fatty Liver Disease Through Arntl‐Sirt1 Pathway

The Lncrna Gm15622 Stimulates SREBP-1c Expression and Hepatic Lipid Accumulation by Sponging the Mir-742-3p in Mice.

Long Non-Coding RNA NEAT1 Inhibits Hepatocyte Proliferation in Fulminant Hepatic Failure Through H3K27me3 Methylation-Dependent Promotion of LATS2

Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance

LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating Mir-206/Arnt Axis

LncRNA Gm12664–001 Ameliorates Nonalcoholic Fatty Liver Through Modulating Mir-295-5p and CAV1 Expression